米非司酮联合米索前列醇片应用于瘢痕子宫中期妊娠引产的开放性、阳性药物随机对照临床试验(4)
第1页 |
参见附件。
[3] 郭燕燕,周世梅.实用妇产科药物治疗学[M].2版.北京:人民卫生出版社,2003:318-319.
[4] 曹泽毅.中华妇产科学[M].北京:人民卫生出版社,2002:2595-2596.
[5] Hou S,Chen Q,Zhang L,et al. Mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate for the termination of second trimester pregnancy:a prospective,open-label,randomized clinical trial [J].Eur J Obstet Gynecol Reprod Biol,2010,151(2):149-153.
[6] Hou SP,Fang AH,Chen QF,et al. Termination of second-trimester pregnancy by mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate(RivanolR):a systematic review of Chinese trials [J]. Contraception,2011,84(3):214-223.
[7] Zhuang Y,Chen X,Huang L,et al. Mifepristone may shorten the induction-to-abortion time for termination of second-trimester pregnancies by ethacridine lactate [J]. Contraception,2012,85(2):211.
[8] Hofmeyr GJ,Gülmezoglu AM,Pileggi C. Vaginal misoprostol for cervical ripening and induction of labour [J]. Cochrane Database Syst Rev,2010,6(10):941-943.
[9] Rahman H,Pradhan A,Kharka L,et al. Comparative evaluation of 50 microgram oral misoprostol and 25 microgram intravaginal misoprostol for induction of labour at term:a randomized trial [J]. J Obstet Gynaecol Can,2013,35(5):408-416.
[10] 丰有吉,沈铿.妇产科学[M].北京:人民卫生出版社,2010:426.
[11] 李春玲.米非司酮配伍利凡诺用于中孕引产临床观察[J].中华实用医药杂志,2005,5(1):38.
[12] 张莉嘉,韩学军,苏慧.米非司酮在利凡诺引产中应用[J].中国计划生育学杂志,1998,8(40):363-364.
[13] 黄红英.乳酸依沙吖啶、米非司酮、米索前列醇不同给药方法用于瘢痕子宫中期妊娠引产的比较[J].中国医药导报,2012,9(17):184-185,187.
[14] 黄晓清.剖宫产后瘢痕子宫中期妊娠引产的方法探讨[J].中国医药导报,2011,8(18):58-60.
(收稿日期:2013-11-07 本文编辑:张瑜杰)
您现在查看是摘要介绍页,详见PDF附件。